Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

The viral vector and plasmid DNA manufacturing market is driven by the growing requirement of specialized therapies, such as gene therapies and vaccines. The growing prevalence of genetic disorders ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...

(MENAFN- GlobeNewsWire - Nasdaq) The market stands on the precipice of unprecedented expansion. Driven by substantial investments, groundbreaking therapeutic pipelines, and advanced technological ...

Ottawa, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The global viral vectors and plasmid DNA manufacturing market size surpassed USD 6.26 billion in 2024 and is estimated to grow from USD 7.26 billion in 2025 ...

Dublin, July 09, 2025 (GLOBE NEWSWIRE) -- The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. The global Viral Vectors and ...

According to Precedence Research, the global viral vectors & plasmid DNA manufacturing market size was estimated at USD 6.26 billion in 2024 and is expected to hit around USD 23.7 billion by 2033, ...

Extracytoplasmic function sigma factors (ECFs) have been successfully used for constructing predictable artificial gene circuits bacteria like Escherichia coli, but their transferability between ...

Plasmid DNA (pDNA) plays a critical role in biopharmaceutical manufacturing — e.g., by providing a template for mRNA synthesis, delivering genes of interest to production cell lines and viral vectors, ...

DUBLIN--(BUSINESS WIRE)--The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Overall world revenue for the viral vectors ...